Chinese version of Website (中国版网站)
Search
Advanced Search
Chinese version of Website (中国版网站)
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2019
Price and Ordering Information
Subscription Rates 2018
Subscription Rates 2017
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
eBooks Website
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2018
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
For Librarians
FAQ’s for e-prints/reprints
Journal Catalog 2018
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author's Benefits Guide
Editorial Policies
General FAQ’s
Guidelines for Guest Editors
Online Manuscript Submission
Journal Catalog 2018
Publication Cycle - Process Flowchart
Publishing Ethics
Reviewer Guidelines
Self-Archiving Policies
Table of Contents Alert
Contact
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
Volume 24, 46 Issues, 2018
Download PDF Flyer
Current Pharmaceutical Design
This journal supports open access
Impact Factor:
2.611
5 - Year Impact Factor:
3
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
More Options
Special Issue Submission
Thematic Issues
Open Access Funding
Advertisement
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
Volume 24, 46 Issues, 2018
Download PDF Flyer
Current Pharmaceutical Design
This journal supports open access
Impact Factor:
2.611
5 - Year Impact Factor:
3
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
More Options
Special Issue Submission
Thematic Issues
Open Access Funding
Current Pharmaceutical Design
This journal supports open access
Quick Links
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
Special Issue Submission
Thematic Issues
Open Access Funding
Impact Factor:
2.611
5 - Year Impact Factor:
3
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
More Options
Submit Manuscripts Online
Editor-in-Chief:
William A. Banks
VAPSHCS/GRECC S-182
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108
USA
View Full Editorial Board
Subscribe
More Options
Purchase Articles
Order Reprints
Contents
Current Pharmaceutical Design
,
Volume 9
- Number 19
Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)].
,
9
(
19
):
iv
Steven Rosenberg
DOI:
10.2174/138161281030900iv
Permissions
Order Reprints
Order Eprints
Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
,
9
(
19
):
1483
- 1498
Todd W. Rockway and Vincent L. Giranda
DOI:
10.2174/1381612033454649
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
,
9
(
19
):
1499
- 1528
Michael Ploug
DOI:
10.2174/1381612033454630
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
,
9
(
19
):
1529
- 1543
Ute Reuning, Stefan Sperl, Charlotte Kopitz, Horst Kessler, Achim Kruger, Manfred Schmitt and Viktor Magdolen
DOI:
10.2174/1381612033454612
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
,
9
(
19
):
1545
- 1564
Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc and Daniel A. Lawrence
DOI:
10.2174/1381612033454621
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Urokinase Receptor and Integrin Interactions
,
9
(
19
):
1565
- 1574
Matthias C. Kugler, Ying Wei and Harold A. Chapman
DOI:
10.2174/1381612033454658
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Webmaster Contact:
info@benthamscience.org
Copyright © 2018 Bentham Science